Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on systemic glucocorticosteroids in dermatology.

L C Williams1, L T Nesbitt

  • 1Department of Dermatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Dermatologic Clinics
|January 13, 2001
PubMed
Summary

Glucocorticosteroids (GCSs) are vital for inflammatory skin diseases, but require careful management. Dermatologists must understand GCS pharmacology, adverse effects, and monitoring guidelines to ensure patient safety and treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Labetalol in severe and resistant hypertension.

British journal of clinical pharmacology·2015
Same author

Orthodeoxia and postural orthostatic tachycardia in patients with pulmonary arteriovenous malformations: a prospective 8-year series.

Thorax·2014
Same author

Chromosome microarray analysis in a clinical environment: new perspective and new challenge.

British journal of biomedical science·2011
Same author

Design, normalization, and analysis of spotted microarray data.

Methods in cell biology·2004
Same author

Systemic glucocorticosteroid therapy in dermatology.

Dermatology nursing·2002
Same author

Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease.

Journal of medical virology·2000

Area of Science:

  • Dermatology
  • Pharmacology
  • Endocrinology

Background:

  • Glucocorticosteroids (GCSs) are essential for managing inflammatory skin conditions.
  • Despite numerous systemic medications, GCSs remain a cornerstone therapy.
  • Effective use necessitates comprehensive knowledge of their properties.

Purpose of the Study:

  • To outline essential guidelines for the clinical use of GCSs in dermatology.
  • To emphasize the importance of understanding GCS pharmacology and adverse effects.
  • To provide a framework for safe and effective GCS management.

Main Methods:

  • Review of GCS guidelines, pharmacology, and adverse effects.
  • Emphasis on understanding the hypothalamic-pituitary-adrenal (HPA) axis.

Related Experiment Videos

  • Inclusion of patient history, physical examinations, and laboratory monitoring.
  • Specific recommendations for evaluating and preventing osteoporosis, infections, and other side effects.

    • Main Results:

    • GCS therapy requires vigilant monitoring for acute and chronic side effects.
    • Key areas for monitoring include bone mineral density, ophthalmologic health, and infection.
    • Proactive management of GCS-induced osteoporosis is crucial, involving nutrition, exercise, and potential pharmacotherapy.
    • Patient education and regular physician evaluations are vital for minimizing risks.

    Conclusions:

    • Dermatologists must possess extensive knowledge of GCSs for optimal patient outcomes.
    • Adherence to monitoring and preventative strategies minimizes GCS-related risks.
    • A collaborative patient-physician relationship enhances GCS therapy safety and effectiveness.
    • Proper management ensures patients receive maximum benefits with minimal adverse effects from GCSs.